This suggested role may provide a molecular mechanism by which TSG101 could act as a tumor suppressor, and it was reported that ‘TSG101-deficient’ SL6 cells exhibited alterations in EGF trafficking that may have caused elevated levels of active MAP kinases following EGF stimulation [34]. This evidence concerns the gene EGF and neoplasm.